Hazel Jones appointed as CEO of Enhanc3D Genomics
We’re delighted to share that Enhanc3D Genomics has announced the appointment of Hazel Jones as CEO, after successfully serving as interim CEO for the last six months.
Enhanc3D Genomics, is a Start Codon portfolio company that is developing disruptive technologies to unlock the 3D genome for use in novel target identification and unique patient stratification.
As COO and interim CEO Hazel has overseen the company’s global business operations and held responsibility for executing its strategic vision for commercial and academic partnerships. She has played a leading role in transitioning the company’s 3D genomics platform from development to practical application in R&D.
We wish Hazel and her team the best of luck as she continues to drive the company towards full commercialisation of its 3D genomics platform.
Find out more: https://enhanc3dgenomics.com/e...